KSKeith Siew

Keith Siew

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Keith Siew has a total of 312 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Salt-Sensitive Hypertension Begins With Intracellular K + and Water Loss

    by Shintaro Minegishi, Norihiko Morisawa, Johannes Wild, Yam Wan Keat, Kaoru Takase-Minegishi, Adriana Marton, Tzy Tiing Lim, Manuela Peukert, Regina Lohmayer, Stephen Walsh, et al.

    BACKGROUND: Na + and water overload due to inappropriately low renal salt and water excretion is considered the root cause of salt-sensitive hypertension. However, experimental renal and psoriasis hypertension are characterized by chronic predisposition to dehydration. We tested the validity of this alternative hypertension due to loss of water theory in deoxycorticosterone acetate (DOCA) salt-sensitive hypertension. METHODS: We tested the effect of DOCA (25 mg pellet) in mice on a low Na + diet (0.02%–0.03%) with tap water, or with Na + in their drinking water (1% NaCl or 1.44% NaHCO 3 ), on body Na + , K + , and water content 2, 6, and 12 days after treatment initiation. We monitored blood pressure with radio-telemetry, food and water intake, and renal electrolyte and water excretion. RESULTS: At day 2, DOCA NaCl-treated mice elevated blood pressure during a state of isolated body K + and water loss, indicating substantial intracellular dehydration. Although increasing their fluid intake and urine output, the mice reduced the excretion of free water, indicating renal water conservation. At days 6 and 12, secondary Na + retention occurred, which replaced the amount of K + lost and corrected the dehydration, albeit at the expense of an intracellular Na + /K + redistribution disorder. DOCA NaHCO 3 -treated mice with Na + -resistant blood pressure showed a comparable Na + /K + redistribution disorder, but without accompanying early dehydration due to earlier replacement of lost K + by Na + . CONCLUSIONS: Experimental DOCA salt-sensitive hypertension initiates with a systemic water conservation response in the face of K + -driven intracellular water loss. Both dehydration and blood pressure increase could be causally treated by oral K + supplementation.

  • Open Access

    Tackling aging and chronic disease: How space exploration and the ‘chameleon effect’ of pharmaceuticals can lead the way

    by Carina Kern, Tina Woods, Keith Siew

    A common misconception surrounding space exploration is that humanity's pursuit of interplanetary travel, such as missions to Mars, is an escape from Earth. In reality, this endeavour offers an invaluable opportunity to address critical biomedical challenges here at home. The extreme conditions of space, including microgravity, cosmic radiation and prolonged isolation, create a natural laboratory for studying human biology under stress, allowing us to explore the boundaries of human resilience. These exposures yield key insights into the biology of aging, the accelerated decline of physiological function and the early onset of chronic diseases. Among the organs most susceptible to environmental stress is the kidney, which is at high risk of failure during long‐duration spaceflight. Its sensitivity makes it an ideal model for understanding how stress accelerates degeneration, both in space and on Earth. By studying kidney function alongside broader cellular processes, we can illuminate how stress drives aging and chronic disease. This is particularly exemplified by the process of cellular necrosis (unprogrammed cell death), which represents a key central node as recently demonstrated. Necrosis acts upstream of processes like cellular senescence and tissue degeneration, and is the mechanism through which multiple environmental factors erode resilience and drive the progression of chronic diseases like kidney disease. Following this exploration of how stress accelerates biological decline, we examine strategies that may protect against such damage, preventing disease and preserving physiological resilience. Pharmaceuticals, with their ability to modulate physiology transiently, are especially powerful in dynamic, real‐world environments where stressors continually change. This ‘chameleon effect’ of pharmaceuticals offers the potential to uncouple biological trade‐offs and enhance adaptive capacity to stress. Understanding these processes in the space environment provides an unprecedented opportunity, difficult to reproduce on Earth, to identify links between exposure and develop targeted interventions to enhance health and resilience on Earth.


  • Open Access

    Bioengineering vascularised composite skin equivalents via Living Assembly through Templated Tissue Integration and Construct Engineering (LATTICE)

    by Sushma Priya, Keith Siew, Prasad Sawadkar, Ali Pirayesh, Afshin Mosahebi, Subha Narayan Rath, Deepak M. Kalaskar

  • Cosmic Kidney Disease

    by Viola D'AMbrosio, Eric P. Cohen, Giovanna Valenti, Keith Siew

  • Top Cited Papers
    Open Access

    Cosmic kidney disease: an integrated pan-omic, physiological and morphological study into spaceflight-induced renal dysfunction

    by Keith Siew, Kevin A Nestler, Charlotte Nelson, Viola D'Ambrosio, Chutong Zhong, Zhongwang Li, Alessandra Grillo, Elizabeth R Wan, Vaksha Patel, Eliah Overbey, et al.

    Missions into Deep Space are planned this decade. Yet the health consequences of exposure to microgravity and galactic cosmic radiation (GCR) over years-long missions on indispensable visceral organs such as the kidney are largely unexplored. We performed biomolecular (epigenomic, transcriptomic, proteomic, epiproteomic, metabolomic, metagenomic), clinical chemistry (electrolytes, endocrinology, biochemistry) and morphometry (histology, 3D imaging, miRNA-ISH, tissue weights) analyses using samples and datasets available from 11 spaceflight-exposed mouse and 5 human, 1 simulated microgravity rat and 4 simulated GCR-exposed mouse missions. We found that spaceflight induces: 1) renal transporter dephosphorylation which may indicate astronauts’ increased risk of nephrolithiasis is in part a primary renal phenomenon rather than solely a secondary consequence of bone loss; 2) remodelling of the nephron that results in expansion of distal convoluted tubule size but loss of overall tubule density; 3) renal damage and dysfunction when exposed to a Mars roundtrip dose-equivalent of simulated GCR.


  • Open Access

    Space radiation damage rescued by inhibition of key spaceflight associated miRNAs

    by J. Tyson McDonald, JangKeun Kim, Lily Farmerie, Meghan L. Johnson, Nidia S. Trovao, Shehbeel Arif, Keith Siew, Sergey Tsoy, Yaron Bram, Jiwoon Park, et al.

    Our previous research revealed a key microRNA signature that is associated with spaceflight that can be used as a biomarker and to develop countermeasure treatments to mitigate the damage caused by space radiation. Here, we expand on this work to determine the biological factors rescued by the countermeasure treatment. We performed RNA-sequencing and transcriptomic analysis on 3D microvessel cell cultures exposed to simulated deep space radiation (0.5 Gy of Galactic Cosmic Radiation) with and without the antagonists to three microRNAs: miR-16-5p, miR-125b-5p, and let-7a-5p (i.e., antagomirs). Significant reduction of inflammation and DNA double strand breaks (DSBs) activity and rescue of mitochondria functions are observed after antagomir treatment. Using data from astronaut participants in the NASA Twin Study, Inspiration4, and JAXA missions, we reveal the genes and pathways implicated in the action of these antagomirs are altered in humans. Our findings indicate a countermeasure strategy that can potentially be utilized by astronauts in spaceflight missions to mitigate space radiation damage.


  • Open Access

    A second space age spanning omics, platforms and medicine across orbits

    by Christopher E. Mason, James Green, Konstantinos I. Adamopoulos, Evan E. Afshin, Jordan J. Baechle, Mathias Basner, Susan M. Bailey, Luca Bielski, Josef Borg, Joseph Borg, et al.

    The recent acceleration of commercial, private, and multi-national spaceflight has created an unprecedented level of activity in low Earth orbit (LEO), concomitant with the highest-ever number of crewed missions entering space and preparations for exploration-class (>1 year) missions. Such rapid advancement into space from many new companies, countries, and space-related entities has enabled a“Second Space Age.” This new era is also poised to leverage, for the first time, modern tools and methods of molecular biology and precision medicine, thus enabling precision aerospace medicine for the crews. The applications of these biomedical technologies and algorithms are diverse, encompassing multi-omic, single-cell, and spatial biology tools to investigate human and microbial responses to spaceflight. Additionally, they extend to the development of new imaging techniques, real-time cognitive assessments, physiological monitoring, and personalized risk profiles tailored for astronauts. Furthermore, these technologies enable advancements in pharmacogenomics (PGx), as well as the identification of novel spaceflight biomarkers and the development of corresponding countermeasures. In this review, we highlight some of the recent biomedical research from the National Aeronautics and Space Administration (NASA), Japan Aerospace Exploration Agency (JAXA), European Space Agency (ESA), and other space agencies, and also detail the commercial spaceflight sector’s (e.g. SpaceX, Blue Origin, Axiom, Sierra Space) entrance into aerospace medicine and space biology, the first aerospace medicine biobank, and the myriad upcoming missions that will utilize these tools to ensure a permanent human presence beyond LEO, venturing out to other planets and moons.


  • Open Access

    Spaceflight causes strain dependent gene expression changes associated with lipid and extracellular matrix dysregulation in the mouse kidney in vivo

    by Rebecca H. Finch, Geraldine Vitry, Keith Siew, Stephen B. Walsh, Afshin Behesti, Gary Hardiman, Willian A. da Silveira

    To explore new worlds we must ensure humans can survive and thrive in the space environment. Incidence of kidney stones in astronauts is a major risk factor associated with long term missions, caused by increased blood calcium levels due to bone demineralisation triggered by microgravity and space radiation. Transcriptomic changes have been observed in other tissues during spaceflight, including the kidney. We analysed kidney transcriptome patterns in two different strains of mice flown on the International Space Station, C57BL/6J and BALB/c. Here we show a link between spaceflight and transcriptome patterns associated with dysregulation of lipid and extracellular matrix metabolism and altered transforming growth factor-beta signalling. A stronger response was seen in C57BL/6J mice than BALB/c. Genetic differences in hyaluronan metabolism between strains may confer protection against extracellular matrix remodelling through downregulation of epithelial-mesenchymal transition. We intend for our findings to contribute to development of new countermeasures against kidney disease in astronauts and people here on Earth. Highlights Spaceflight has a significant effect on gene expression in the kidney. Responses in the BALB/c indicate milder transcriptomic perturbations than C57BL/6J. Lipid metabolism was altered in both strains of mice. Extracellular matrix metabolism and TGF-β signalling up in BALB/c down in C57BL/6J. Reduced gene expression of hyaluronan synthesis pathway in BALB/c but not in C57BL/6J.


  • Open Access

    Mammalian Cell Models of the Distal Convoluted Tubule: A Systematic Review of Cell Lines, Culture Condition and Gene Expression

    by Chutong Zhong, Zhen Sun, Alessandra Grillo, Stephen B Walsh, Keith Siew

    This review examines the crucial role of human cellular models in renal physiology research, with a specific focus on the distal convoluted tubule (DCT). It aims to provide a comprehensive summary of the origins, culture practices, and genetic studies associated with commonly employed DCT cell models. To achieve this, a systematic literature review was performed on Europe PMC, employing a Boolean search strategy. A total of 6,559 articles were initially screened, resulting in 301 articles on human-origin cell models, 69 on murine models, and 29 on canine models being included in the final analysis. Notably, the review identified two studies that introduced novel immortalised human DCT cell lines developed from primary DCT cells. This paper provides a detailed account of the lineage of each cell model, their prevalent culture conditions, and the frequency and nature of gene transfections—both wild type and mutant—conducted in these models. A significant observation from the analysis was the inconsistent reporting of methodological details across studies, which compromises the reproducibility of the research. Additionally, there was a considerable variation in culture conditions and transfection methods used across different studies. The review also highlights that HEK293 family and murine DCT cell lines do not serve as accurate models for DCT cells, pointing out the frequent need for transfecting DCT-specific genes to simulate DCT functionality adequately. NEW & NOTEWORTHY This review is the first review to detail the current state of play with cell models of the distal convoluted tubule, including endogenous protein expression, culture conditions etc. We expect this review to be of great utility to established and early career researchers who are interested in nephrological or hypertensive patho/physiology. We have highlighted some important gaps in reporting the established cell models, we think that this kind of review is important for open science.

  • Open Access

    Author Correction: The kidney, volume homeostasis and osmoregulation in space: current perspective and knowledge gaps

    by Rik H. G. Olde Engberink, Paula J. van Oosten, Tobias Weber, Kevin Tabury, Sarah Baatout, Keith Siew, Stephen B. Walsh, Giovanna Valenti, Alexander Chouker, Pierre Boutouyrie, et al.